Buy Day today: Neutral (56) Mixed market breadth · no major macro event

Edwards Lifesciences Corp

Healthcare · Medical Devices

86.30$ +0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Edwards Lifesciences Corp (EW) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 6,068 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement EW
Line item	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	905	804	692	704	861	932	998	1,037	1,091	1,238	1,321	1,447	1,679	1,900	2,046	2,323	2,494	2,964	3,435	3,723	4,348	4,386	5,233	5,382	6,005	5,440	6,068
Cost of Revenue	466	423	324	299	359	370	375	383	381	409	399	410	461	507	544	631	684	806	883	922	1,155	1,099	1,226	1,167	1,380	1,118	1,327
Gross Profit	439	381	368	405	501	561	623	654	710	829	922	1,037	1,218	1,393	1,502	1,692	1,809	2,158	2,552	2,801	3,193	3,287	4,007	4,215	4,625	4,322	4,741
Research & Development	55	55	55	65	73	87	99	114	122	139	176	204	246	291	323	347	383	442	553	622	753	761	903	945	1,072	1,053	1,079
Selling, General & Administrative	233	216	203	228	290	320	349	376	418	481	509	550	642	705	746	858	851	905	985	1,089	1,242	1,228	1,494	1,567	1,756	1,789	2,085
Total Operating Expenses	322	286	344	353	363	407	448	490	540	620	684	754	889	996	1,069	1,205	1,234	1,342	1,542	1,708	1,995	1,991	2,396	2,513	2,896	2,943	3,105
Operating Income	117	95	24	52	138	154	176	164	170	209	238	283	329	397	433	487	576	816	1,010	1,092	1,198	1,296	1,610	1,702	1,534	1,379	1,636
Interest Expense	0.0	0.0	23	12	13	14	12	11	9.1	7.2	1.1	2.4	3.1	4.4	5.8	22	18	18	23	33	27	22	25	26	18	20	20
Pre-Tax Income	113	-259	-9.0	56	93	30	117	172	150	164	304	268	284	391	515	1,144	622	738	1,035	761	1,167	917	1,702	1,767	1,598	1,548	1,273
Income Tax Expense	31	13	1.0	0.3	14	28	37	42	37	36	75	50	47	98	124	333	128	168	451	39	120	93	199	246	199	152	217
Net Income	82	-272	-12	56	79	1.7	79	131	113	129	229	218	237	293	392	811	495	570	622	722	1,047	823	1,503	1,522	1,402	4,175	1,074
EBITDA	201	169	81	93	184	100	185	240	214	227	297	327	345	453	590	1,234	707	827	1,140	872	1,308	1,074	1,890	1,960	1,534	1,723	1,430

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings